The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Oncorus, Inc(NASDAQ:ONCR)


Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Ph...
Website: http://www.oncorus.com
Founded: 2015
Full Time Employees: 51
CEO: Theodore T. Ashburn
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Oncorus Op Cashflow Per Share ttm
Oncorus Free Cashflow Per Share ttm
Oncorus Cash Per Share ttm
Oncorus (GAAP) P/E ratio ttm
Oncorus P/B ratio ttm
No extra charts and metrics for this ticker.